Member Info for dewilliams

I sold my position for a loss a fortnight ago on the basis that the stock looked like it was continuing its southern journey. I was right. There is no point in buying dips, as the stock has only been dipping lower. I may get back in again but only when the stock proves itself by going up, stabilising and making a new relevant high.

I used to have this stock as an investment but got rid of it for a loss. Never again. Lots of promises; no delivery. US equivalents have performed very well over the past year. But IQE's lack of progress leaves a lot to be desired.

Correction: second sentence: Why are you *not*

C'mon IQE. Apple is soaring in the US and its IPhones are still selling well. Why are you to riding on the back of their success? Why are you not penetrating other markets? Why is the CEO paid so much while the company is faltering? Show some respect to your shareholders and start taking such a high salary when the company actually starts to make money. Or step down and put in someone new with a fiery vision who can drive sales. IQE needs to show much better management and a commitment to secure sales. This will help restore confidence and drive up the share price.

IQE's price has been recovering but this is due to the semi-conductor sector in general. Micron Technology in the US had a 13%+ share price increase, and Intel and other stocks have risen. Qd22's account was interesting, and I hope the spare capacity will soon be humming rather than looking like a potential white elephant.

What a nice surprise. I check my share portfolio to see it drop again, this time courtesy of IQE. I want to see some real strong direction here. This company needs to be taken forward rather than going backwards. IQE needs orders. It needs someone who is going to bring a lot of business into the company.

The share has consolidation at 5.50 based on the bid. I can't see any big movement above 5.50 unless a rival bid emerges.

The more I think about it, the more this deal stinks.The board valued the company at around 7.50 per share last summer when it rejected the previous bid. Why has the board changed its position big time? That's a huge difference in valuation.

More than 9m shares trades today, and the resistance is at 5.50, unsurprisingly. We'll know something is definitely afoot if the price climbs higher.

Having bought in at around £7.50 you can imagine how I feel about this. I certainly wouldn't vote to accept this offer. I might not get my purchase price but I would like it to get much closer to the mark. I hope the valuation proves to be much higher and a rival bid emerges.

I will add that today's losses will bounce back over a week or so.

I don't think we have to panic here. As another poster said, most of the "news" of the report has already been built into the price. What interests me is the poor judgements re: operations. IQE is writing off $4m on a bad lease in Singapore, and it has had to restructure its US operations, particularly in New Jersey. Oddly, the death of its financial director was one of its key financial contributors last year owing, presumably, to key man insurance. IQE should benefit from the deal it struck with the Welsh government of its new leased building It does need to keep operation costs down to help contribute to profit in a very competitive sector.

Good points and questions. If the answers are not forthcoming these should be raised at the agm.

Anyone know whether there were large sales last night, which resulted in the drop? I presume the price won't rise too much today as gold has dropped.

Update: anyone know why the price has suddenly fallen?

Basically, if you are shorting shares you are, in effect, selling them first, with the tacit agreement you will be buying them from your broker at a later date. So, when IQE spikes at 99p as a trader I might think, "Hey, this looks likely to retrace to 85p. Let's go for it" That's good business for a short trade at 14p per share minus trading fees. IQE is seen as a good day trading stock because of its Yo Yo-like movements, volume and volatility. I believe IQE will eventually spike and sustain itself at a higher price so shorters have to make very sure they get out before that happens otherwise they lose. In the US markets, a common shorting ground is pharmaceuticals based on FDA reports of drugs undergoing approval in phases. Most drugs fail, and shorts are placed on the day negative results are reported.

What about the losses in Latin America? How do they figure in the overall equation?

What a difference an institution makes! When a big concern starts gobbling up shares the price goes up. What I don't know is why now. After months of investors bashing their heads in here at a continued slide in the SP, IQE's price starts gaining some traction and upward momentum. I'm not complaining—just an observation.

Much better performance. Still a long way to go but at least some encouraging signs.

I watched this recent interview with the company's CEO, which points to good times ahead. The CEO says he is also mystified why his company's share price is experiencing a roller-caster despite all internal signs looking good. htTps://m.youtube.com/watch?v=FI_LmHSJsR4